Which lipid is the main precursor of gangliosides?
True biosynthetic origin gangliosides traces ceramide rather than glycerophospholipid scaffolds explaining sphingolipidosis pathogenesis and therapeutic targeting. De novo ceramide formation begins serine palmitoyltransferase SPTLC1 SPTLC2 condensing serine palmitoyl CoA then three ketodihydrosphingosine reductase KDSR ceramide synthases CERS1 six DES1 DES2 desaturase ER membrane. Ceramide trafficked Golgi by CERT transfer protein START domain PH domain dependent PI4P binding glucosylated UGCG on cytosolic face forming glucosylceramide flipped P4 ATPase ATP10D ABCA12 lumen galactosylated B4GALT5 six to lactosylceramide branch point for globo lacto ganglio series. Sialyltransferase ST3GAL5 converts lactosylceramide GM3 precursor GD3 GT3 complex a b series via B4GALNT1 GalT ST8SIA1 ST6GALNAC enzymes adding GalNAc Gal sialic acid. Phosphatidylcholine provides phosphocholine SM but not sugar chain gangliosides cholesterol triacylglycerol unrelated storage. Understanding ceramide arrow GlcCer arrow LacCer arrow GM3 cascade explains substrate reduction therapy miglustat eliglustat inhibiting UGCG for Gaucher gangliosidosis and biomarker strategies. Therefore ceramide represents central lipid precursor recognized textbooks pathway maps glycosphingolipid biosynthesis universally accepted consensus in lipid biochemistry and cell biology curricula advanced levels.
Ref: Kolter et al., FEBS Letters 2002, Ceramide glucosylceramide lactosylceramide ganglioside precursor pathway biosynthesis.